Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion
Stylized representation of digital health

Keys to harnessing the value of digital biomarkers in clinical trials

  • Biopharma , 
  • Medtech , 
  • Digital , 
Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.

Read more

A Kaplan-Meier view of oncology development

  • Biopharma , 
  • Digital , 
We refresh a prior analysis of two cohorts of oncology development pro…

Read more

Multi-Cancer Early Detection tests – Will they become part of regular clinical care?

PDF here Summary The idea of a single blood-test to detect many cancer…

Read more

The road ahead for genomic testing

  • Biopharma , 
  • Payers , 
  • Medtech , 
New molecular diagnostics, especially tests based on next-generation s…

Read more

Boiling the Ocean…or not

  • Payers , 
  • Providers , 
  • Digital , 
We've all heard the term, "Boiling the Ocean" to refer to an approach …

Read more